Form 4 for FULC Fulcrum Therapeutics, Inc.
Accepted 2023-05-11 00:00:00 ET · period of report 2023-05-10 · accession 0000950170-23-021245 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-11 | 2023-05-10 | FULC | Tourangeau Greg | Principal Accounting Off | S - Sale | $3.31 | -210 | 16.0K | -1% | -$695.10 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-10 | S | D | 210 | $3.31 | 15,992 | D | — | — |